Literature DB >> 12042665

The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promoter.

Fabrice Morel1, Claudine Rauch, Brian Coles, Eric Le Ferrec, André Guillouzo.   

Abstract

By searching the human genome sequence database with human hGSTA1 and hGSTA4 cDNA sequences, we identified three PAC and one BAC clones covering more than 400 kilobases and containing the entire GST alpha gene cluster. The cluster consists of five genes: hGSTA1, hGSTA2, hGSTA3, hGSTA4 and hGSTA5, and seven pseudogenes that are distinguished as such by single-base and/or complete exon deletions. Using gene-specific probes we demonstrated that hGSTA1, hGSTA2 and hGSTA4 mRNAs are widely expressed in human tissues, whereas hGSTA3 mRNA appears to be a rare message subject to splicing defects. Although examination of the hGSTA5 gene sequence suggests that it is a functional gene, hGSTA5 mRNA could not be detected in human tissues we studied. hGSTA1 expression has been shown to be influenced by a genetic polymorphism, that consists of two alleles hGSTA1*A and hGSTA1*B, containing three linked base substitutions in the proximal promoter, at positions -567, -69 and -52. Constructs consisting of the luciferase gene controlled by variant hGSTA1 promoters showed differential expression when transfected into HepG2, GLC4 and Caco-2 cells: hGSTA1*A > hGSTA1*B. Directed mutagenesis for each base substitution indicated that the base change -52G>A was responsible for the differential promoter activity of hGSTA1*A and hGSTA1*B. The base at position -52 also altered binding of the ubiquitous transcription factor Sp1, as determined by gel shift analysis. Thus it may be postulated that hGSTA1 genotyping will be of importance to determine individual susceptibility to certain cancers or the efficacy of chemotherapeutics via its effect on hGSTA1 expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042665     DOI: 10.1097/00008571-200206000-00003

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  25 in total

1.  Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population.

Authors:  Yasuhiro Komiya; Hiromasa Tsukino; Hiroyuki Nakao; Yoshiki Kuroda; Hirohisa Imai; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-23       Impact factor: 4.553

2.  The human hGSTA5 gene encodes an enzymatically active protein.

Authors:  Sharda P Singh; Ludwika Zimniak; Piotr Zimniak
Journal:  Biochim Biophys Acta       Date:  2009-08-04

3.  In silico characterization and comparative genomic analysis of the Culex quinquefasciatus glutathione S-transferase (GST) supergene family.

Authors:  B P Niranjan Reddy; G B K S Prasad; K Raghavendra
Journal:  Parasitol Res       Date:  2011-04-15       Impact factor: 2.289

4.  Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation.

Authors:  Francesca Bonifazi; Gianluca Storci; Giuseppe Bandini; Elena Marasco; Elisa Dan; Elena Zani; Fiorenzo Albani; Sara Bertoni; Andrea Bontadini; Sabrina De Carolis; Maria Rosaria Sapienza; Simonetta Rizzi; Maria Rosa Motta; Martina Ferioli; Paolo Garagnani; Michele Cavo; Vilma Mantovani; Massimiliano Bonafè
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

5.  Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy.

Authors:  Ann M Moyer; Zhifu Sun; Anthony J Batzler; Liang Li; Daniel J Schaid; Ping Yang; Richard M Weinshilboum
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

6.  Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.

Authors:  Song Yao; William E Barlow; Kathy S Albain; Ji-Yeob Choi; Hua Zhao; Robert B Livingston; Warren Davis; James M Rae; I-Tien Yeh; Laura F Hutchins; Peter M Ravdin; Silvana Martino; Alan P Lyss; C Kent Osborne; Martin Abeloff; Gabriel N Hortobagyi; Daniel F Hayes; Christine B Ambrosone
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

7.  Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.

Authors:  Nikhil K Khankari; Patrick T Bradshaw; Lauren E McCullough; Susan L Teitelbaum; Susan E Steck; Brian N Fink; Xinran Xu; Jiyoung Ahn; Christine B Ambrosone; Katherine D Crew; Mary Beth Terry; Alfred I Neugut; Jia Chen; Regina M Santella; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2013-11-27       Impact factor: 2.506

8.  Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.

Authors:  P David Josephy
Journal:  Hum Genomics Proteomics       Date:  2010-06-13

Review 9.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Influence of glutathione-related genes on symptoms and immunologic markers among vulcanization workers in the southern Sweden rubber industries.

Authors:  Lena S Jönsson; Bo A G Jönsson; Anna Axmon; Margareta Littorin; Karin Broberg
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.